Clinical Trials on Anemia, Refractory

Total 6873 results

Oriflame Cosmetics AB
Karolinska Institutet

Withdrawn

Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women

Anaemia

Sweden
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Bioequivalence Study of Hetrombopag in Healthy Subjects

Sever Aplastic Anaemia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

Sever Aplastic Anaemia

China
King Faisal Specialist Hospital & Research Center

Completed

Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia

Acquired Aplastic Anaemia
GlaxoSmithKline

Completed

Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

Anaemia

United States
GlaxoSmithKline
Octagon Research Solutions, Incoporated

Completed

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil) (DDI)

Anaemia

India
National Cancer Institute (NCI)

Completed

Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia

Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia

United States
HaEmek Medical Center, Israel

Completed

The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.

Iron Deficiency Anemias

Israel
GlaxoSmithKline

Completed

Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers

Anaemia

United States
University of Giessen
MVZ für Laboratoriumsmedizin Koblenz; Deutscher Drachenboot Verband e.V.

Completed

Iron Metabolism in Dragon Boat Athletes

Anaemia
Fundación Canaria Rafael Clavijo para la Investigación...

Completed

Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation

Anaemia

Spain
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of Hetrombopag in Healthy Subjects

Sever Aplastic Anaemia

China
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid... and other conditions

United States
Imperial College Healthcare NHS Trust

Completed

Treatment Response in Dialysis Anaemia (PRIME)

Anaemia | Haemodialysis

United Kingdom
Samsung Medical Center

Unknown

Intravenous Iron Injection in Cancer Patients With Anemia

Cancer Anaemia

Korea, Republic of
University of East Anglia
Quadram Institute Bioscience

Completed

Iron & Alginate Study

Iron Deficiency | Anaemia

United Kingdom
Pharmacosmos A/S

Completed

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Pharmacosmos A/S
Laboratory Corporation of America; BioStata; ClinStar, LLC

Completed

IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose (Provide)

Iron Deficiency Anaemia

United States
Fred Hutchinson Cancer Center
Jazz Pharmaceuticals

Terminated

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid Neoplasm

United States
Sichuan Huiyu Pharmaceutical Co., Ltd
The First Hospital of Jilin University; Suzhou Guochen Biotek Co., Ltd.; Boji... and other collaborators

Completed

Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia

Iron Deficiency | Anaemia

China
Maastricht University Medical Center
Vifor Pharma

Terminated

The Use of Iron Therapy for Patients With Anemia After Caesarean Section (VITAPOP)

Postoperative Anaemia

Netherlands
Sandoz

Completed

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

Mild and Moderate Iron-deficiency Anaemia

Russian Federation
American Regent, Inc.

Withdrawn

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Iron Deficiency, Anaemia

United States
Universiti Kebangsaan Malaysia Medical Centre

Unknown

'MyPinkMom' Educational Intervention for Pregnant Women With Anaemia

Anaemia in Pregnancy
University of British Columbia
Ministry of Health, Zambia; UNICEF; Tropical Disease Research Centre

Completed

Zambia Micronutrient Powder Trial Effectiveness Study

Stunting | Iron Deficiency Anaemia

Zambia
Ruijin Hospital

Recruiting

Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

Myelodysplastic Syndromes | Myelodysplastic Syndrome With Excess Blasts-2 | Myelodysplastic Syndrome With Excess Blasts-1

China
University of Kinshasa
KU Leuven

Completed

Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa

Sickle-Cell Anaemia

Congo, The Democratic Republic of the
Pharmacosmos A/S

Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
University of Maryland, Baltimore

Completed

Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women

Non-anemic Iron Deficiency

United States
University of Cape Town
University of Stellenbosch; University of KwaZulu

Not yet recruiting

South African Paediatric Surgical Outcomes Study 2 (SAPSOS2)

Iron Deficiency Anemia | Anaemia | Iron | Prospective Studies | Paediatric Surgery | Interventional Studies
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia

Steroid-refractory Diamond-Blackfan Anemia (DBA)

United States
Iowa State University

Completed

Effect of Iron Supplements on the Growth of Enteric Pathogens

Iron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia Treatment | Iron Deficiency Anaemia Due to Dietary Causes

United States
Shanghai East Hospital

Unknown

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

Chemotherapy-induced Anaemia

China
The Hospital for Sick Children
Canadian Institutes of Health Research (CIHR); Unity Health Toronto; Mount Sinai... and other collaborators

Completed

Iron Treatment for Young Children With Non-anemic Iron Deficiency (OptEC)

Non-anemic Iron Deficiency

Canada
Pharmacosmos A/S

Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Iron Deficiency Anemia | Iron Deficiency Anaemia

United States
Muhimbili University of Health and Allied Sciences
University of Pittsburgh; Muhimbili National Hospital

Unknown

Mobile-Directly Observed Therapy on Adherence to Hydroxyurea (mDOT)

Sickle Cell Anaemia
Institute of Child Health

Unknown

Prevention Of Morbidity In Sickle Cell Disease Pilot Phase

Sickle Cell Anaemia

United Kingdom
University of Washington
National Cancer Institute (NCI)

Completed

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Chronic Myelomonocytic Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22... and other conditions

United States
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease (CAD0111)

Refractory Cold Agglutinin Disease

Italy
Bioverativ, a Sanofi company

Active, not recruiting

Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088

Autoimmune Haemolytic Anaemia

Netherlands, Germany, Italy, Norway, United Kingdom
Bioverativ, a Sanofi company

Completed

A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease

Autoimmune Haemolytic Anaemia

United States, Germany, Italy, Netherlands, Norway, United Kingdom
London School of Hygiene and Tropical Medicine

Completed

Iron Babies Pilot Supplementation Trial (Iron Babies)

Iron-deficiency | Anaemia in Early Infancy

Gambia
London School of Hygiene and Tropical Medicine
National Institute for Medical Research, Tanzania

Completed

A Trial of 2 'Point of Care' Diagnostic Methods to Improve Detection and Treatment of Anaemia in African Children (EARS)

Anaemia

Tanzania
National Cancer Institute (NCI)

Active, not recruiting

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Acute Erythroid Leukemia | Acute Megakaryoblastic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Refractory Anemia | Myelodysplastic Syndrome With Ring Sideroblasts

United States
Carleton University
Hopital Montfort; University of Ottawa; Lucky Iron Fish Enterprise

Recruiting

Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age

Iron Deficiency | Iron Deficiency Anaemia

Canada
London School of Hygiene and Tropical Medicine
King's College London; Wellcome Trust; University of Cambridge; National Nutrition... and other collaborators

Completed

A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial (IHAT-Gut)

Iron Deficiency, Anaemia in Children

Gambia
Stony Brook University

Recruiting

Treatment of Non-Anemic Iron Deficiency in Pregnancy

Non-anemic Iron Deficiency

United States
Stichting Hemato-Oncologie voor Volwassenen Nederland
Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)

Recruiting

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy (HOVON150AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
Stichting Hemato-Oncologie voor Volwassenen Nederland
Astellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...

Active, not recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
London School of Hygiene and Tropical Medicine
Maseno University, Maseno, Kenya

Completed

Safe and Efficacious Iron for Children in Kenya (SEICK)

Anaemia

Kenya

Clinical Trials on Anemia, Refractory

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations